The Impact of Continuous Veno-Venous Hemodiafiltration on the Efficacy of Administration of Prophylactic Doses of Enoxaparin: A Prospective Observational Study.

Aleksander Aszkiełowicz Karol P SteckiewiczMichał OkrągłyMagdalena A WujtewiczRadoslaw Owczuk

Published in: Pharmaceuticals (Basel, Switzerland) (2023)

CVVHDF has only a mild effect on the enoxaparin prophylactic effect measured by anti-Xa factor activity. Thus, it seems there is no need to increase the dose of enoxaparin for patients requiring CVVHDF.

Keyphrases

venous thromboembolism
end stage renal disease
ejection fraction
extracorporeal membrane oxygenation
prognostic factors
peritoneal dialysis